JERUSALEM--(BUSINESS WIRE)--Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., the technology transfer arm of the University, today announced that it has licensed a novel package of stem cell related technologies to TheraCell, Inc. (California, USA), which will further develop and commercialize the technology for advanced regenerative medicine procedures such as spinal fusion. The technology was invented by a team headed by Professor Dan Gazit from the Faculty of Dental Medicine at the Hebrew University of Jerusalem.
